<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>von Willebrand | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of von Willebrand Disease (vWD)  Definition: The most common inherited bleeding disorder, characterized by a quantitative (amount) or qualitative (functional) defect in von Willebrand...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="von Willebrand | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of von Willebrand Disease (vWD)  Definition: The most common inherited bleeding disorder, characterized by a quantitative (amount) or qualitative (functional) defect in von Willebrand...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="von Willebrand | Hematology">
<meta name="twitter:description" content="Overview of von Willebrand Disease (vWD)  Definition: The most common inherited bleeding disorder, characterized by a quantitative (amount) or qualitative (functional) defect in von Willebrand...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="active" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Hematology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="von-willebrand" class="section level1 unnumbered">
<h1>von Willebrand<a class="anchor" aria-label="anchor" href="#von-willebrand"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-von-willebrand-disease-vwd" class="section level2 unnumbered">
<h2>
<strong>Overview of von Willebrand Disease (vWD)</strong><a class="anchor" aria-label="anchor" href="#overview-of-von-willebrand-disease-vwd"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> The most common inherited bleeding disorder, characterized by a quantitative (amount) or qualitative (functional) defect in von Willebrand factor (vWF)</li>
<li>
<strong>Prevalence:</strong> Estimated to affect 1-3% of the population, though many cases are mild and undiagnosed</li>
<li>
<strong>Key Features:</strong>
<ul>
<li>Mucocutaneous bleeding: Easy bruising, nosebleeds (epistaxis), gum bleeding, menorrhagia (heavy menstrual bleeding)</li>
<li>Prolonged bleeding after cuts, dental procedures, or surgery</li>
</ul>
</li>
<li>
<strong>Genetic Basis:</strong> vWD is usually inherited as an autosomal dominant trait, although autosomal recessive inheritance is possible in some subtypes.</li>
<li>
<strong>Treatment:</strong> Varies depending on the type and severity of vWD, and may include desmopressin, vWF/FVIII concentrates, and antifibrinolytic agents</li>
</ul>
</div>
<div id="von-willebrand-factor-vwf-structure-and-function" class="section level2 unnumbered">
<h2>
<strong>von Willebrand Factor (vWF): Structure and Function</strong><a class="anchor" aria-label="anchor" href="#von-willebrand-factor-vwf-structure-and-function"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>vWF Structure:</strong>
<ul>
<li>A large, multimeric glycoprotein found in plasma, platelets, and subendothelial connective tissue</li>
<li>Synthesized by endothelial cells and megakaryocytes</li>
<li>Monomers of vWF are assembled into dimers, which then polymerize to form large multimers</li>
<li>The size and structure of vWF multimers are critical for its function</li>
</ul>
</li>
<li>
<strong>vWF Functions:</strong>
<ul>
<li>**Platelet Adhesion:
<ul>
<li>vWF binds to exposed collagen in the subendothelium of damaged blood vessels</li>
<li>vWF then binds to the platelet glycoprotein Ib/IX/V (GPIb/IX/V) receptor on the platelet surface, mediating initial platelet adhesion</li>
<li>This interaction is crucial for platelet plug formation at sites of vascular injury, especially under high shear stress conditions</li>
</ul>
</li>
<li>**Factor VIII Carrier:
<ul>
<li>vWF binds to factor VIII (FVIII), a coagulation protein</li>
<li>vWF protects FVIII from degradation and prolongs its half-life in the circulation</li>
<li>Decreased vWF can lead to decreased FVIII levels</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="classification-of-vwd" class="section level2 unnumbered">
<h2>
<strong>Classification of vWD</strong><a class="anchor" aria-label="anchor" href="#classification-of-vwd"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Type 1 vWD:</strong> (60-80% of cases)</p>
<ul>
<li>Partial quantitative deficiency of vWF</li>
<li>vWF is present, but in reduced amounts</li>
<li>All vWF multimers are present, but in decreased concentration</li>
<li>Inheritance: Usually autosomal dominant</li>
</ul>
</li>
<li>
<p><strong>Type 2 vWD:</strong> (20-30% of cases)</p>
<ul>
<li>Qualitative defects in vWF function</li>
<li>vWF is present in normal or near-normal amounts, but its ability to perform its functions is impaired</li>
<li>Subtypes:
<ul>
<li>Type 2A:
<ul>
<li>Decreased high-molecular-weight vWF multimers</li>
<li>Impaired platelet adhesion</li>
<li>Often caused by increased proteolysis or abnormal multimer assembly</li>
</ul>
</li>
<li>Type 2B:
<ul>
<li>Increased affinity of vWF for platelets</li>
<li>Spontaneous binding of vWF to platelets, leading to clearance of both vWF and platelets from the circulation, resulting in thrombocytopenia</li>
<li>Ristocetin-induced platelet aggregation (RIPA) is enhanced at low concentrations of ristocetin</li>
</ul>
</li>
<li>Type 2M:
<ul>
<li>Decreased binding of vWF to platelets or collagen</li>
<li>Normal vWF multimer distribution</li>
<li>Differentiation of subtypes depends on which binding activity is affected (platelets or collagen)</li>
</ul>
</li>
<li>Type 2N:
<ul>
<li>Decreased binding of vWF to factor VIII</li>
<li>Markedly reduced factor VIII levels</li>
<li>May be misdiagnosed as mild hemophilia A (factor VIII deficiency)</li>
</ul>
</li>
</ul>
</li>
<li>Inheritance: Usually autosomal dominant</li>
</ul>
</li>
<li>
<p><strong>Type 3 vWD:</strong> (Rare)</p>
<ul>
<li>Severe quantitative deficiency of vWF (vWF is virtually absent)</li>
<li>Very low or undetectable levels of vWF and factor VIII</li>
<li>Severe bleeding symptoms</li>
<li>Inheritance: Autosomal recessive</li>
</ul>
</li>
</ul>
</div>
<div id="clinical-features-1" class="section level2 unnumbered">
<h2>
<strong>Clinical Features</strong><a class="anchor" aria-label="anchor" href="#clinical-features-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Variable bleeding symptoms:</strong></p>
<ul>
<li>Severity of bleeding depends on the type and severity of vWD</li>
<li>Bleeding symptoms may be mild and only become apparent after surgery or trauma</li>
</ul>
</li>
<li>
<p><strong>Common Manifestations:</strong></p>
<ul>
<li>Nosebleeds (epistaxis)</li>
<li>Easy bruising</li>
<li>Prolonged bleeding after cuts or dental procedures</li>
<li>Menorrhagia (heavy menstrual bleeding) in women</li>
<li>Postpartum hemorrhage</li>
<li>Gastrointestinal bleeding (less common)</li>
<li>Joint bleeds (hemarthrosis) are rare, unlike in hemophilia</li>
</ul>
</li>
<li>
<p><strong>Symptoms by vWD Type:</strong></p>
<ul>
<li>Type 1 vWD: Mild to moderate bleeding symptoms</li>
<li>Type 2 vWD: Variable bleeding symptoms, depending on the subtype
<ul>
<li>Type 2A: Moderate bleeding symptoms</li>
<li>Type 2B: Moderate bleeding symptoms; may also have thrombocytopenia</li>
<li>Type 2M: Mild to moderate bleeding symptoms</li>
<li>Type 2N: Moderate to severe bleeding symptoms; may be misdiagnosed as hemophilia A</li>
</ul>
</li>
<li>Type 3 vWD: Severe bleeding symptoms</li>
</ul>
</li>
</ul>
</div>
<div id="laboratory-diagnosis" class="section level2 unnumbered">
<h2>
<strong>Laboratory Diagnosis</strong><a class="anchor" aria-label="anchor" href="#laboratory-diagnosis"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Screening Tests:</strong></p>
<ul>
<li>Complete Blood Count (CBC):
<ul>
<li>Platelet count is usually normal, but may be decreased in some cases (e.g., type 2B vWD)</li>
</ul>
</li>
<li>Prothrombin Time (PT): Usually normal</li>
<li>Activated Partial Thromboplastin Time (aPTT): May be prolonged if factor VIII is significantly reduced (especially in type 2N and type 3 vWD)</li>
</ul>
</li>
<li>
<p><strong>Specific vWD Assays:</strong></p>
<ul>
<li>von Willebrand Factor Antigen (vWF:Ag):
<ul>
<li>Measures the amount of vWF protein in the plasma</li>
<li>Decreased in type 1 and type 3 vWD</li>
<li>May be normal in type 2 vWD</li>
</ul>
</li>
<li>von Willebrand Factor Activity (vWF:RCo):
<ul>
<li>Measures the ability of vWF to bind to platelets using ristocetin as a cofactor</li>
<li>Ristocetin-induced platelet aggregation (RIPA)</li>
<li>Decreased in most types of vWD (except for type 2B, where it is increased)</li>
</ul>
</li>
<li>Factor VIII Activity (FVIII:C):
<ul>
<li>Measures the activity of factor VIII</li>
<li>May be decreased in vWD, especially in type 2N and type 3</li>
</ul>
</li>
<li>vWF Multimer Analysis:
<ul>
<li>Evaluates the distribution of vWF multimers</li>
<li>Decreased high molecular weight multimers in type 2A vWD</li>
</ul>
</li>
<li>Platelet Function Analyzer (PFA-100):
<ul>
<li>Measures platelet function under high shear stress</li>
<li>Prolonged closure time in most types of vWD</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Diagnostic Approach:</strong></p>
<ol style="list-style-type: decimal">
<li>Perform Initial Screening Tests (CBC, PT, aPTT)</li>
<li>Measure vWF:Ag and vWF:RCo:
<ul>
<li>If both are decreased -&gt; Consider type 1 or type 3 vWD</li>
<li>If vWF:Ag is normal but vWF:RCo is decreased -&gt; Consider type 2 vWD</li>
</ul>
</li>
<li>Perform FVIII:C Assay:
<ul>
<li>If FVIII:C is decreased -&gt; Consider type 2N vWD</li>
</ul>
</li>
<li>Perform vWF Multimer Analysis:
<ul>
<li>To differentiate type 2A from other subtypes</li>
</ul>
</li>
<li>Perform RIPA at low concentrations of ristocetin:
<ul>
<li>To identify type 2B vWD (RIPA is enhanced)</li>
</ul>
</li>
<li>Genetic Testing: May be considered in some cases to confirm the diagnosis or classify the subtype of vWD</li>
</ol>
</li>
</ul>
</div>
<div id="treatment-2" class="section level2 unnumbered">
<h2>
<strong>Treatment</strong><a class="anchor" aria-label="anchor" href="#treatment-2"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Desmopressin (DDAVP):</strong></p>
<ul>
<li>A synthetic analog of vasopressin that stimulates the release of vWF and factor VIII from endothelial cells</li>
<li>Effective in treating type 1 vWD and some subtypes of type 2 vWD</li>
<li>Administered intravenously, subcutaneously, or intranasally</li>
<li>Side effects: Flushing, headache, hyponatremia (low sodium)</li>
</ul>
</li>
<li>
<p><strong>vWF/Factor VIII Concentrates:</strong></p>
<ul>
<li>Plasma-derived concentrates that contain both vWF and factor VIII</li>
<li>Used to treat bleeding episodes or for prophylaxis in patients with severe vWD or those who do not respond to DDAVP</li>
<li>Examples: Humate-P, Alphanate SDH, Wilate</li>
</ul>
</li>
<li>
<p><strong>Antifibrinolytic Agents:</strong></p>
<ul>
<li>Tranexamic acid or aminocaproic acid</li>
<li>Inhibit fibrinolysis (the breakdown of blood clots)</li>
<li>Used to prevent or treat bleeding, especially mucosal bleeding (e.g., menorrhagia, dental procedures)</li>
</ul>
</li>
<li>
<p><strong>Topical Hemostatic Agents:</strong></p>
<ul>
<li>Thrombin-soaked gauze or fibrin sealants</li>
<li>Used to control local bleeding</li>
</ul>
</li>
<li>
<p><strong>Other Considerations:</strong></p>
<ul>
<li>Avoid Aspirin and NSAIDs: These medications can impair platelet function and increase the risk of bleeding</li>
<li>Hormonal Therapy: Oral contraceptives or other hormonal treatments may be used to manage menorrhagia</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-44" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-44"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>von Willebrand Factor (vWF):</strong> A protein that mediates platelet adhesion and carries factor VIII</li>
<li>
<strong>vWF Antigen (vWF:Ag):</strong> Measures the amount of vWF protein</li>
<li>
<strong>vWF Activity (vWF:RCo):</strong> Measures the ability of vWF to bind to platelets</li>
<li>
<strong>Factor VIII (FVIII:C):</strong> A coagulation protein that is carried by vWF</li>
<li>
<strong>Ristocetin-Induced Platelet Aggregation (RIPA):</strong> A test used to assess vWF function</li>
<li>
<strong>Desmopressin (DDAVP):</strong> A synthetic analog of vasopressin that stimulates the release of vWF and factor VIII</li>
<li>
<strong>Multimers:</strong> Polymers of vWF subunits</li>
<li>
<strong>Platelet Function Analyzer (PFA):</strong> A test that measures platelet function under high shear stress</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
</script><div class="chapter-nav">
<div class="prev"><a href="qualitative.html">Qualitative</a></div>
<div class="next"><a href="bernard-soulier.html">Bernard-Soulier</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#von-willebrand">von Willebrand</a></li>
<li><a class="nav-link" href="#overview-of-von-willebrand-disease-vwd">Overview of von Willebrand Disease (vWD)</a></li>
<li><a class="nav-link" href="#von-willebrand-factor-vwf-structure-and-function">von Willebrand Factor (vWF): Structure and Function</a></li>
<li><a class="nav-link" href="#classification-of-vwd">Classification of vWD</a></li>
<li><a class="nav-link" href="#clinical-features-1">Clinical Features</a></li>
<li><a class="nav-link" href="#laboratory-diagnosis">Laboratory Diagnosis</a></li>
<li><a class="nav-link" href="#treatment-2">Treatment</a></li>
<li><a class="nav-link" href="#key-terms-44">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Hematology/blob/blob/main/Rmd/03-11-platelet-qualitative-vwd.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Hematology/blob/edit/main/Rmd/03-11-platelet-qualitative-vwd.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-02-28 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
